Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$4.23 - $7.53 $58,382 - $103,929
-13,802 Reduced 55.56%
11,039 $48,000
Q3 2022

Nov 10, 2022

BUY
$8.96 - $14.7 $16,307 - $26,754
1,820 Added 7.91%
24,841 $280,000
Q2 2022

Aug 12, 2022

BUY
$6.52 - $13.24 $150,096 - $304,798
23,021 New
23,021 $292,000
Q3 2021

Nov 12, 2021

SELL
$4.89 - $7.82 $95,501 - $152,724
-19,530 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$4.61 - $6.83 $145,629 - $215,759
-31,590 Reduced 61.8%
19,530 $121,000
Q1 2021

May 14, 2021

BUY
$6.19 - $16.0 $316,432 - $817,920
51,120 New
51,120 $378,000

Others Institutions Holding PRPH

About ProPhase Labs, Inc.


  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $10.1M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.